A citation-based method for searching scientific literature

Laszlo Szpisjak, Denes Zadori, Peter Klivenyi, Laszlo Vecsei. CNS Neurol Disord Drug Targets 2019
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Commentary: Recalling Memory by Brain Stimulation.
Ting Liu, Mingchen Fu, Oscar Arias-Carrion, Ti-Fei Yuan. CNS Neurol Disord Drug Targets 2017
1
100


In vitro Magnetic Stimulation: A Simple Stimulation Device to Deliver Defined Low Intensity Electromagnetic Fields.
Stephanie Grehl, David Martina, Catherine Goyenvalle, Zhi-De Deng, Jennifer Rodger, Rachel M Sherrard. Front Neural Circuits 2016
10
33

Transcranial Magnetic Stimulation on Rodent Models.
Cristina Estrada, Ernesto Tarragon, Joan B Kelley, Dolores Lopez, Ana Luisa Gil-Martínez, Emiliano F Villalba, Maria-Trinidad Herrero. CNS Neurol Disord Drug Targets 2016
4
33

Repetitive Transcranial Magnetic Stimulation, Cognition, and Multiple Sclerosis: An Overview.
Grigorios Nasios, Lambros Messinis, Efthimios Dardiotis, Panagiotis Papathanasopoulos. Behav Neurol 2018
13
33

Fire Needle Acupuncture Regulates Wnt/ERK Multiple Pathways to Promote Neural Stem Cells to Differentiate into Neurons in Rats with Spinal Cord Injury.
Jiachun Xu, Suli Cheng, Zhaohua Jiao, Zhiheng Zhao, Zhimin Cai, Nan Su, Baohong Liu, Zhen Zhou, Yan Li. CNS Neurol Disord Drug Targets 2019
8
33

Repetitive Transcranial Magnetic Stimulation (rTMS)-Induced Trigeminal Autonomic Cephalalgia.
Onur Durmaz, Mehmet Alpay Ateş, Mehmet Güney Şenol. Noro Psikiyatr Ars 2015
4
33


Neuromodulation-dependent effect of gated high-frequency, LFMS-like electric field stimulation in mouse cortical slices.
Ehsan Negahbani, Stephen L Schmidt, Nadia Mishal, Flavio Fröhlich. Eur J Neurosci 2019
1
100

Possible Mechanisms Underlying the Therapeutic Effects of Transcranial Magnetic Stimulation.
Alexander V Chervyakov, Andrey Yu Chernyavsky, Dmitry O Sinitsyn, Michael A Piradov. Front Hum Neurosci 2015
110
33

Transcranial Magnetic Stimulation as a Therapeutic Option for Neurologic and Psychiatric Illnesses.
Sara Habib, Umair Hamid, Ayesha Jamil, Aariz Z Zainab, Tooba Yousuf, Sana Habib, Syed Maaz Tariq, Faryal Ali. Cureus 2018
2
50

Mechanism of Action for rTMS: A Working Hypothesis Based on Animal Studies.
Thangavelu Soundara Rajan, Maria F M Ghilardi, Hoau-Yan Wang, Emanuela Mazzon, Placido Bramanti, Domenico Restivo, Angelo Quartarone. Front Physiol 2017
17
33


Activation of Kir2.3 Channels by Tenidap Suppresses Epileptiform Burst Discharges in Cultured Hippocampal Neurons.
Xunyi Wu, Zhiyun Chen, Wanbing Sun, Guoxiang Wang, Lu Zhang, Yuwen Zhang, Kai Zang, Yun Wang. CNS Neurol Disord Drug Targets 2019
1
100

Translational Challenge Models in Support of Efficacy Studies: Neurobehavioral and Cognitive Changes Induced by Transcranial Magnetic Stimulation in Healthy Volunteers.
Pablo Martin-Trias, Véronique Bragulat, Cleofé Peña-Gómez, Roser Sala-Llonch, Laura Lanteaume, Catherine Cassé-Perrot, Olivier Blin, Joëlle Micallef, Alexandra Auffret, David Bartrés-Faz. CNS Neurol Disord Drug Targets 2016
3
33

High-frequency magnetic stimulation induces long-term potentiation in rat hippocampal slices.
Tursonjan Tokay, Norman Holl, Timo Kirschstein, Volker Zschorlich, Rüdiger Köhling. Neurosci Lett 2009
37
33

COMMENTARY: Transcranial Magnetic Stimulation in Multiple Sclerosis: A Method to Improve Movement.
Francisco J Medina-Fernandez, Begona M Escribano, Isaac Tunez. CNS Neurol Disord Drug Targets 2017
2
50

Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment.
Emanuela Onesti, Vittorio Frasca, Marco Ceccanti, Giorgio Tartaglia, Maria Cristina Gori, Chiara Cambieri, Laura Libonati, Eleonora Palma, Maurizio Inghilleri. CNS Neurol Disord Drug Targets 2019
5
33

Repetitive low intensity magnetic field stimulation in a neuronal cell line: a metabolomics study.
Ivan Hong, Andrew Garrett, Garth Maker, Ian Mullaney, Jennifer Rodger, Sarah J Etherington. PeerJ 2018
4
33


Neurobiological after-effects of non-invasive brain stimulation.
G Cirillo, G Di Pino, F Capone, F Ranieri, L Florio, V Todisco, G Tedeschi, K Funke, V Di Lazzaro. Brain Stimul 2017
119
33

Frequency-specific effects of repetitive magnetic stimulation on primary astrocyte cultures.
Darren Clarke, Marissa A Penrose, Tamasin Penstone, Paula I Fuller-Carter, Livia C Hool, Alan R Harvey, Jennifer Rodger, Kristyn A Bates. Restor Neurol Neurosci 2017
15
33

Blockade of in vitro ictogenesis by low-frequency stimulation coincides with increased epileptiform response latency.
Toshiyuki Kano, Yuji Inaba, Margherita D'Antuono, Giuseppe Biagini, Maxime Levésque, Massimo Avoli. J Neurophysiol 2015
7
33


Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients.
Vittorio Schweiger, Alvise Martini, Paola Bellamoli, Katia Donadello, Carlo Schievano, Giovanna D Balzo, Piercarlo Sarzi-Puttini, Massimo Parolini, Enrico Polati. CNS Neurol Disord Drug Targets 2019
11
33

Brain Magnetic Stimulation in Animal Models: A Valuable Lesson for Clinical Applications.
Begona M Escribano, Abel Santamaría, María E de Lima, Francisco J Medina-Fernández, Shahid Bashir, Isaac Túnez. CNS Neurol Disord Drug Targets 2016
3
33

Pain-Related Behavior and Brain Activation in a Cynomolgus Macaque Model of Postoperative Pain.
Aldric Hama, Takahiro Natsume, Shin Ya Ogawa, Yuji Awaga, Ikuo Hayashi, Akihisa Matsuda, Hiroyuki Takamatsu. CNS Neurol Disord Drug Targets 2018
10
33

Non-invasive Cerebellar Stimulation in Cerebellar Disorders.
Chiara Di Nuzzo, Fabiana Ruggiero, Francesca Cortese, Ilaria Cova, Alberto Priori, Roberta Ferrucci. CNS Neurol Disord Drug Targets 2018
8
33

Repetitive magnetic stimulation of human-derived neuron-like cells activates cAMP-CREB pathway.
Julian Hellmann, Rene Jüttner, Clarisse Roth, Malek Bajbouj, Imke Kirste, Isabella Heuser, Karen Gertz, Matthias Endres, Golo Kronenberg. Eur Arch Psychiatry Clin Neurosci 2012
24
33

VaD - An Integrated Framework for Cognitive Rehabilitation.
Maria Balea, Dafin Muresanu, Anton Alvarez, Volker Homberg, Ovidiu Bajenaru, Alla Guekht, Wolf-Dieter Heiss, Livia Popa, Johannes Vester, Ioana Muresanu,[...]. CNS Neurol Disord Drug Targets 2018
4
33

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).
Jean-Pascal Lefaucheur, Nathalie André-Obadia, Andrea Antal, Samar S Ayache, Chris Baeken, David H Benninger, Roberto M Cantello, Massimo Cincotta, Mamede de Carvalho, Dirk De Ridder,[...]. Clin Neurophysiol 2014
922
33

Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2.
Luis Velázquez Pérez, Gilberto Sánchez Cruz, Nalia Canales Ochoa, Roberto Rodríguez Labrada, Julio Rodríguez Díaz, Luis Almaguer Mederos, José Laffita Mesa. J Neurol Sci 2007
34
33

Polyglutamine toxicity induces rod photoreceptor division, morphological transformation or death in spinocerebellar ataxia 7 mouse retina.
Marina G Yefimova, Nadia Messaddeq, Alice Karam, Carine Jacquard, Chantal Weber, Laurent Jonet, Uwe Wolfrum, Jean-Claude Jeanny, Yvon Trottier. Neurobiol Dis 2010
15
33

Two patients with spinocerebellar ataxia type 7 presenting with profound binocular visual loss yet minimal ophthalmoscopic findings.
Matthew J Thurtell, J Alexander Fraser, Elisa Bala, Robert L Tomsak, Valérie Biousse, R John Leigh, Nancy J Newman. J Neuroophthalmol 2009
10
33

Neuro-ophthalmologic features of spinocerebellar ataxia type 7.
Randee C Miller, Aash Tewari, Joel A Miller, James Garbern, Gregory P Van Stavern. J Neuroophthalmol 2009
27
33

The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype).
S Geiner, A K E Horn, N H Wadia, H Sakai, J A Büttner-Ennever. Prog Brain Res 2008
26
33

Macular degeneration as a common cause of visual loss in spinocerebellar ataxia type 1 (SCA1) patients.
Koji M Nishiguchi, Masashi Aoki, Toru Nakazawa, Toshiaki Abe. Ophthalmic Genet 2019
4
33


The SAGA coactivator complex acts on the whole transcribed genome and is required for RNA polymerase II transcription.
Jacques Bonnet, Chen-Yi Wang, Tiago Baptista, Stéphane D Vincent, Wei-Chun Hsiao, Matthieu Stierle, Cheng-Fu Kao, László Tora, Didier Devys. Genes Dev 2014
113
33


Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.
G David, N Abbas, G Stevanin, A Dürr, G Yvert, G Cancel, C Weber, G Imbert, F Saudou, E Antoniou,[...]. Nat Genet 1997
599
33

Spinocerebellar Ataxia Type 17 (SCA17).
Yasuko Toyoshima, Hitoshi Takahashi. Adv Exp Med Biol 2018
8
33

Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2.
L Velázquez-Pérez, C Seifried, M Abele, F Wirjatijasa, R Rodríguez-Labrada, N Santos-Falcón, G Sánchez-Cruz, L Almaguer-Mederos, R Tejeda, N Canales-Ochoa,[...]. Clin Neurophysiol 2009
54
33

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.
Pavitra S Ramachandran, Sajag Bhattarai, Pratibha Singh, Ryan L Boudreau, Stewart Thompson, Albert R Laspada, Arlene V Drack, Beverly L Davidson. PLoS One 2014
26
33

Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice.
Edgardo Rodríguez-Lebrón, Maria do Carmo Costa, Katiuska Luna-Cancalon, Therese M Peron, Svetlana Fischer, Ryan L Boudreau, Beverly L Davidson, Henry L Paulson. Mol Ther 2013
70
33

Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias.
Christopher D Stephen, Jeremy D Schmahmann. Cerebellum 2019
8
33

Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features.
Ji Sun Kim, Ji Soo Kim, Jinyoung Youn, Dae-Won Seo, Yuri Jeong, Ji-Hoon Kang, Jeong Ho Park, Jin Whan Cho. Mov Disord 2013
28
33

Regulation of calcium channel alpha(1A) subunit splice variant mRNAs in kainate-induced temporal lobe epilepsy.
S Vigues, M Gastaldi, C Chabret, A Massacrier, P Cau, J Valmier. Neurobiol Dis 1999
24
33

Chromosomal assignment of the second locus for autosomal dominant cerebellar ataxia (SCA2) to chromosome 12q23-24.1.
S Gispert, R Twells, G Orozco, A Brice, J Weber, L Heredero, K Scheufler, B Riley, R Allotey, C Nothers. Nat Genet 1993
290
33

Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
Sandro Alves, Isabel Nascimento-Ferreira, Noëlle Dufour, Raymonde Hassig, Gwennaëlle Auregan, Clévio Nóbrega, Emmanuel Brouillet, Philippe Hantraye, Maria C Pedroso de Lima, Nicole Déglon,[...]. Hum Mol Genet 2010
74
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.